|
LSM5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.23940002494783E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.45119999747945E-08 |
| Normal-vs-Stage2 |
3.100200E-02 |
| Normal-vs-Stage3 |
4.819700E-02 |
| Normal-vs-Stage4 |
2.797800E-02 |
| Stage1-vs-Stage2 |
7.739200E-01 |
| Stage1-vs-Stage3 |
7.657700E-02 |
| Stage1-vs-Stage4 |
7.156800E-01 |
| Stage2-vs-Stage3 |
3.376800E-01 |
| Stage2-vs-Stage4 |
6.780600E-01 |
| Stage3-vs-Stage4 |
1.514190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.71420000206047E-09 |
| Normal-vs-AfricanAmerican |
1.66111999999607E-05 |
| Normal-vs-Asian |
2.524800E-01 |
| Caucasian-vs-AfricanAmerican |
8.373000E-01 |
| Caucasian-vs-Asian |
7.112200E-01 |
| AfricanAmerican-vs-Asian |
7.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09799996767168E-09 |
| Normal-vs-Female |
1.57273999999985E-05 |
| Male-vs-Female |
2.938600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.188900E-04 |
| Normal-vs-Extreme_Weight |
5.39129999532761E-08 |
| Normal-vs-Obese |
2.62449999999248E-06 |
| Normal-vs-Extreme_Obese |
2.671400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.576800E-01 |
| Normal_Weight-vs-Obese |
6.798000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.376800E-01 |
| Extreme_Weight-vs-Obese |
5.749200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.033600E-01 |
| Obese-vs-Extreme_Obese |
3.028600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.497400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.69819999676457E-08 |
| Normal-vs-Age(61-80Yrs) |
1.07700000029354E-07 |
| Normal-vs-Age(81-100Yrs) |
4.942000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.456800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.933600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.483200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.036000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.674400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.605200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.54241072639161E-14 |
| Normal-VS-Type2 PRCC |
1.208760E-01 |
| Normal-VS-KIRP CIMP |
7.250100E-02 |
| Normal-VS-Unclassified PRCC |
4.509800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.58829682318196E-11 |
| Type1 PRCC-VS-KIRP CIMP |
1.710140E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.10070000000018E-05 |
| Type2 PRCC-VS-KIRP CIMP |
5.923800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.935600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.854800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.060450E-02 |
| Normal-vs-N1 |
1.981610E-03 |
| Normal-vs-N2 |
3.865800E-01 |
| N0-vs-N1 |
2.670600E-01 |
| N0-vs-N2 |
4.060600E-01 |
| N1-vs-N2 |
7.485800E-01 |
|
|
